‘Digital Pill’ Lets Doctors Know It’s Been Taken

Share:
Facebook Twitter Google+

The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, and to help control episodes of either manic or “mixed” episodes for people with bipolar disorder.

WebMD Health

Commenti

commenti